{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:06:53Z","timestamp":1791216413144,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1136\/ard.2006.058644","type":"journal-article","created":{"date-parts":[[2007,2,4]],"date-time":"2007-02-04T01:47:45Z","timestamp":1170553665000},"page":"1276-1283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies"],"prefix":"10.1016","volume":"66","author":[{"given":"Sevim Barbasso","family":"Helmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dastmalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Alexanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Nennesmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Esbj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Lindvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.058644_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","article-title":"NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy,","volume":"122","author":"Plotz","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.058644_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.058644_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1136\/ard.2006.058644_bib4","first-page":"940","article-title":"Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis","volume":"27","author":"Nyberg","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.058644_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","article-title":"Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy","volume":"53","author":"De Bleecker","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1136\/ard.2006.058644_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(95)00045-4","article-title":"Expression of cell adhesion molecules in inflammatory myopathies","volume":"59","author":"Tews","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1136\/ard.2006.058644_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2249.1994.tb06032.x","article-title":"MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies","volume":"95","author":"Bartoccioni","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2006.058644_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","article-title":"Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis","volume":"43","author":"Lundberg","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.058644_bib9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.058644_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","article-title":"Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease","volume":"2","author":"Leung","year":"1989","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.058644_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","article-title":"A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM","volume":"56","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1136\/ard.2006.058644_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1136\/ard.2006.058644_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0140-6736(90)91630-S","article-title":"Intravenous immunoglobulin for polymyositis and dermatomyositis","volume":"336","author":"Cherin","year":"1990","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.058644_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang","year":"1991","journal-title":"Am J Med"},{"key":"10.1136\/ard.2006.058644_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.058644_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.058644_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.058644_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1136\/ard.2006.058644_bib19","first-page":"1380","article-title":"A functional index in myositis","volume":"23","author":"Josefson","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.058644_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0404.1979.tb02942.x","article-title":"\u201cSemi-open\u201d muscle biopsy technique. A simple outpatient procedure","volume":"59","author":"Henriksson","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1136\/ard.2006.058644_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1136\/ard.2006.058644_bib22","first-page":"717","article-title":"Subclinical myositis is common in primary Sjogren's syndrome and is not related to muscle pain","volume":"29","author":"Lindvall","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.058644_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF02335664","article-title":"High-dose intravenous immunoglobulin in myasthenia gravis","volume":"14","author":"Evoli","year":"1993","journal-title":"Ital J Neurol Sci"},{"key":"10.1136\/ard.2006.058644_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08830188909061987","article-title":"The immunologic effects of IVIG in Kawasaki disease","volume":"5","author":"Leung","year":"1989","journal-title":"Int Rev Immunol"},{"key":"10.1136\/ard.2006.058644_bib25","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","article-title":"Intravenous immunoglobulin in autoimmune neuromuscular diseases","volume":"291","author":"Dalakas","year":"2004","journal-title":"JAMA"},{"key":"10.1136\/ard.2006.058644_bib26","first-page":"403","article-title":"Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions","volume":"109","author":"Krause","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1136\/ard.2006.058644_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.humimm.2005.01.029","article-title":"Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura","volume":"66","author":"Jin","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1136\/ard.2006.058644_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1994.tb00855.x","article-title":"Pooled human IgG modulates cytokine production in lymphocytes and monocytes","volume":"139","author":"Andersson","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1136\/ard.2006.058644_bib29","first-page":"29","article-title":"High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels","volume":"10","author":"Gottfried","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1136\/ard.2006.058644_bib30","first-page":"211","article-title":"Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG","volume":"79","author":"Andersson","year":"1993","journal-title":"Immunology"},{"key":"10.1136\/ard.2006.058644_bib31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","article-title":"International consensus on preliminary definitions of improvement in adult and juvenile myositis","volume":"50","author":"Rider","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.058644_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1469-7793.2000.00243.x","article-title":"Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies","volume":"529","author":"Malm","year":"2000","journal-title":"J Physiol"},{"key":"10.1136\/ard.2006.058644_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/ard.58.8.493","article-title":"Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements","volume":"58","author":"Cunnane","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.058644_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jlb.59.2.287","article-title":"Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis","volume":"59","author":"Bj\u00f6rk","year":"1996","journal-title":"J Leukoc Biol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.058644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T04:09:51Z","timestamp":1737259791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724346448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0003496724346448"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.058644","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.058644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 2007 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}